Delusional disorder, unspecified type and Rhabdomyolysis

Summary:

Rhabdomyolysis is found among people with Delusional disorder, unspecified type, especially for people who are female, 60+ old.

The study analyzes which people have Rhabdomyolysis with Delusional disorder, unspecified type. It is created by eHealthMe based on reports of 11 people who have Delusional disorder, unspecified type from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Delusional disorder, unspecified type?

Delusional disorder, unspecified type is found to be associated with 184 drugs and 228 conditions by eHealthMe. Check the latest studies of Delusional disorder, unspecified type.

What is Rhabdomyolysis?

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down) is found to be associated with 1,554 drugs and 1,922 conditions by eHealthMe. Check the latest studies of Rhabdomyolysis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

11 people who have Delusional Disorder, Unspecified Type and Rhabdomyolysis are studied.

Would you have Rhabdomyolysis when you have Delusional disorder, unspecified type?

Gender of people who have Delusional Disorder, Unspecified Type and experienced Rhabdomyolysis *:

female: 70 %
male: 30 %

Age of people who have Delusional Disorder, Unspecified Type and experienced Rhabdomyolysis *:

Common co-existing conditions for these people *:

Delusional Disorder, Persecutory Type (a belief that they (or someone close to them) are being mistreated): 2 people, 18.18%
Abnormal Behavior: 1 person, 9.09%

Common drugs taken by these people *:

Common symptoms for these people *:

Camptocormia (abnormal posture of the trunk): 6 people, 54.55%
Transaminases Increased: 4 people, 36.36%
Blood Creatine Phosphokinase Increased: 4 people, 36.36%
C-Reactive Protein Increased: 4 people, 36.36%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 18.18%
Dehydration (dryness resulting from the removal of water): 2 people, 18.18%
Endocarditis (inflammation in heart muscle): 2 people, 18.18%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 2 people, 18.18%
Vision Blurred: 1 person, 9.09%
Fever: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Rhabdomyolysis?

- Check whether Rhabdomyolysis is associated with a drug or a condition

Related publications that referenced our studies

Rezigh, A. B., Armenia, E., Li, T., & Soesilo, I. , "Rifaximin as a rare cause of rhabdomyolysis in cirrhosis", Clinical case reports, 2018 Jan .
Moye, P. M., Manasen, S., & O’Brien, K., "Sulfamethoxazole-Trimethoprim-Induced Rhabdomyolysis in an Immunocompetent Patient: A Case Report", Medicine, 2014 Jan .
Rezigh, A. B., Armenia, E., Li, T., & Soesilo, I. , "Rifaximin as a rare cause of rhabdomyolysis in cirrhosis", Clinical case reports, 2018 Jan .
Moye, P. M., Manasen, S., & O’Brien, K., "Sulfamethoxazole-Trimethoprim-Induced Rhabdomyolysis in an Immunocompetent Patient: A Case Report", Medicine, 2014 Jan .

Related studies:

Treatments, associated drugs and conditions:

Delusional disorder, unspecified type (1,797 reports)
Rhabdomyolysis (60,893 reports)

All the drugs that are associated with Rhabdomyolysis:

Rhabdomyolysis (1,554 drugs)

All the conditions that are associated with Rhabdomyolysis:

Rhabdomyolysis (1,922 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Rhabdomyolysis and Delusional disorder, unspecified type, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.